Adicet Bio, Inc.

ACET chart

Adicet Bio, Inc. news

• Adicet Bio at Guggenheim conference: lupus data lifts pivotal hopes

  Investing.com · Nov 10, 1:09 PM EST

• Adicet Bio secures FDA IND clearance for ADI-212 prostate cancer therapy

  scanx.trade · Nov 8, 5:28 AM EST

• Adicet Bio reports 54% remission in prula-cel lupus Phase 1 study

  scanx.trade · Nov 7, 12:27 PM EST

• Guggenheim maintains Adicet Bio at Buy, lowers price target to $55 from $90

  TradingView · Nov 6, 11:01 AM EST

• Wedbush Maintains Adicet Bio(ACET.US) With Buy Rating, Maintains Target Price $28

  Moomoo · Nov 6, 9:36 AM EST

• What Is the Pivotal Program for Prula-cel Mean for Adicet Bio, Inc. (NASDAQ:ACET) in 2027?

  Kalkine · Nov 6, 7:01 AM EST

• ADICET Bio, Inc. reports results for the quarter ended September 30 - Earnings Summary

  TradingView · Nov 5, 8:46 PM EST

• Adicet Bio (ACET) Misses Q3 EPS by 18c

  StreetInsider · Nov 5, 6:25 PM EST

• Adicet Bio Q3 Results: Loss widens to $1.76 per share, misses estimates

  scanx.trade · Nov 5, 4:56 PM EST

• Adicet Bio Reports Q3 2026 Net Loss of $18.9 Million and Updates Pipeline

  TradingView · Nov 5, 4:38 PM EST

• Adicet Bio 3Q 2026: EPS ($1.76) — 10-Q Summary

  TradingView · Nov 5, 4:22 PM EST

• Adicet Bio Reports Third Quarter 2026 Financial Results and Provides Business Updates

  Yahoo Finance · Nov 5, 4:10 PM EST

Adicet Bio, Inc. key financials

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 10-Q10-Q2026-11-05
• 8-K8-K2026-11-05
• 8-K8-K2026-09-28
• 8-K8-K2026-09-08
• 8-K8-K2026-09-01
• 10-Q10-Q2026-08-05
• 8-K8-K2026-08-05
• 8-K8-K2026-06-18
• 10-K/A10-K/A2026-05-20
• 10-Q10-Q2026-05-13
• 8-K8-K2026-05-13
• DEF 14ADEF 14A2026-04-29

About Adicet Bio, Inc.

Ticker

ACET (Nasdaq)

Industry

Pharmaceutical Preparations

Headquarters

Boston, MA

Incorporated in

DE

Fiscal year end

December 26

SEC CIK

1720580

Former names

resTORbio, Inc.

Frequently asked questions